JVPLabs (JRAS Medical Inc.)

Optimal Congestive Heart Failure (CHF) management requires detection of increasing cardiac filling pressures. Current alternatives require a surgical implantable device and are expensive. JVPLabs enables physicians to monitoring increasing cardiac pressures using a non-invasive medical device that accurately measures the Jugular Venous Pressure (JVP). We have automated the current standard of care by simplifying the complex, time-consuming and inaccurate task of JVP assessment. Monitoring the JVP height is the cornerstone for in-hospital management of CHF as it enables medication adjustment, discharge planning and nutritional recommendations. JVP assessment requires a physician at the bedside and unfortunately, is not available in the...

Medical device and medical technology

Jvplabs (jras medical inc.) operates in the Medical device industry.

Jvplabs (jras medical inc.)'s revenue is 11m - 100m

Jvplabs (jras medical inc.) has 11 - 50 employees.